Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma

A J Silman1

  • 1ARC Epidemiology Research Unit, University of Manchester Medical School, UK.

Bailliere'S Clinical Rheumatology
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

Classifying scleroderma is usually straightforward due to distinct skin symptoms. Early or limited scleroderma can be challenging to differentiate from severe Raynaud

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Activity outcomes after hip arthroplasty: an information tool based on patients' experience captured in a hospital registry.

BMC musculoskeletal disorders·2025
Same author

The different influence of high levels of physical activity on the incidence of knee OA in overweight and obese men and women-a gender specific analysis.

Osteoarthritis and cartilage·2019
Same author

Mapping existing hip and knee replacement registries in Europe.

Health policy (Amsterdam, Netherlands)·2018
Same author

Frailty Is Associated with Impaired Quality of Life and Falls in Middle-Aged and Older European Men.

The Journal of frailty & aging·2016
Same author

Vertebral Scheuermann's disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2015
Same author

Epidemiological evidence against a role for C-reactive protein causing leptin resistance.

European journal of endocrinology·2012
Same journal

Regional soft tissue pains: alias myofascial pain?

Bailliere's clinical rheumatology·1999
Same journal

The knee

Bailliere's clinical rheumatology·1999
Same journal

The elbow, forearm, wrist and hand

Bailliere's clinical rheumatology·1999
Same journal

Shoulder disorders: a state-of-the-art review

Bailliere's clinical rheumatology·1999
Same journal

The neck

Bailliere's clinical rheumatology·1999
Same journal

Treatment options for regional musculoskeletal pain: what is the evidence?

Bailliere's clinical rheumatology·1999
See all related articles

Area of Science:

  • Rheumatology
  • Dermatology
  • Connective Tissue Diseases

Background:

  • Scleroderma classification is generally less complex than other connective tissue diseases due to characteristic skin manifestations.
  • Early and limited scleroderma present diagnostic challenges, often overlapping with severe Raynaud's phenomenon.

Purpose of the Study:

  • To evaluate the classification of scleroderma, particularly in early and limited disease stages.
  • To explore the clinical and biological rationale for dividing scleroderma into distinct groups based on early disease characteristics.

Main Methods:

  • Review of clinical presentation and diagnostic criteria for scleroderma.
  • Analysis of disease progression in relation to skin involvement patterns.
  • Assessment of the utility of clinical skin scoring for monitoring disease activity.

Related Experiment Videos

Main Results:

  • Distinctive skin involvement simplifies scleroderma classification in most cases.
  • Truncal skin involvement in early disease provides a biologically and clinically relevant division.
  • Clinical skin score measurement is the optimal method for tracking disease progress.

Conclusions:

  • Scleroderma classification is aided by characteristic skin patterns, though early/limited disease requires careful distinction from Raynaud's phenomenon.
  • A classification system based on early truncal skin involvement offers clinical utility.
  • Clinical skin scoring remains the gold standard for monitoring scleroderma progression.